Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.
about
Nano-palladium is a cellular catalyst for in vivo chemistryThird row transition metals for the treatment of cancerSolid-phase synthesis as a platform for the discovery of new ruthenium complexes for efficient release of photocaged ligands with visible light.Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer.A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin.A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress.The contrasting catalytic efficiency and cancer cell antiproliferative activity of stereoselective organoruthenium transfer hydrogenation catalysts.Platinum compounds for high-resolution in vivo cancer imaging.The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles.Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low ToxicitySynthesis and Assessment of Antibacterial Activities of Ruthenium(III) Mixed Ligand Complexes Containing 1,10-Phenanthroline and GuanideA breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complexMono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms.Ni(II) Complexes with Schiff Base Ligands: Preparation, Characterization, DNA/Protein Interaction and Cytotoxicity Studies.Oxidative metalation as a route to size-mismatched macrocyclic complexes: osmium corroles.Transfer Hydrogenation and Antiproliferative Activity of Tethered Half-Sandwich Organoruthenium Catalysts.In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance
P2860
Q33903811-C895039F-C7E2-467E-A3E3-772D6330E516Q35128394-60D2DA7A-5B64-4276-898E-EAD740343207Q35547191-2A94957B-A6F3-4AF3-BCEC-AA24DF760DEBQ35895492-133C363D-5617-41F2-9FE7-61F2EEE971A5Q37687110-E651E5D4-D6B1-459E-A7D4-A414526252BEQ37709331-7C2683D8-EE43-450C-B76A-4F62F5BEBB89Q38713515-3206E217-C43E-4D3B-B550-300B671E07A7Q38775808-B1BAB6ED-4048-47E1-92A8-E6449F1ED33CQ39026285-57A59D0D-EBB9-4788-AABA-C165B5CE6700Q39256222-D439F439-C718-4FDF-857E-EFEE2D3D0B15Q39824889-A2E58449-1D66-4893-8CBB-1F7B79EB2DB2Q41132341-25FCC787-8E4B-45CC-AF01-EA627CF026F1Q41643582-B09F9B34-4DA6-4DEF-BB28-826DDE1460CFQ42113076-A6CF673F-6535-4D13-8293-26C6C7614F54Q46559447-82034423-7EA0-4FE8-85AB-8B1962871B78Q47416474-D300D6FE-FFE1-4240-A133-B6C496BC8D65Q47428798-6A1A5B65-1A60-4EE3-82B2-F5931FF534EBQ54978767-770D394B-94E9-4981-B761-04AFCDB9EC6BQ56982978-C62C6518-0D38-4216-A40C-7CD4D4C4F833
P2860
Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Bidentate ligands on osmium
@nl
Bidentate ligands on osmium(VI ...... eting and cell death pathways.
@en
type
label
Bidentate ligands on osmium
@nl
Bidentate ligands on osmium(VI ...... eting and cell death pathways.
@en
prefLabel
Bidentate ligands on osmium
@nl
Bidentate ligands on osmium(VI ...... eting and cell death pathways.
@en
P2093
P2860
P356
P1476
Bidentate ligands on osmium(VI ...... eting and cell death pathways.
@en
P2093
Kogularamanan Suntharalingam
Michael T Hemann
Stephen J Lippard
P2860
P304
14060-14063
P356
10.1021/JA4075375
P407
P577
2013-09-16T00:00:00Z